Ani Pharmaceuticals (ANIP) Debt to Equity (2019 - 2023)
Ani Pharmaceuticals (ANIP) posted Debt to Equity of $0.84 for Q1 2023, little changed sequentially from $0.84 in Q4 2022, and up 1.65% YoY from $0.83 in Q1 2022.
Ani Pharmaceuticals (ANIP) Debt to Equity (2019 - 2023) Analysis & Trends
Ani Pharmaceuticals has reported Debt to Equity for 5 years, with the latest figure at $0.84 in Q1 2023.
- Quarterly Debt to Equity rose 1.65% year-over-year to $0.84 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $0.84 (up 1.65% YoY) and the FY2022 annual result came in at $0.84, up 5.34% from the prior year.
- Debt to Equity steadied at $0.84 in Q1 2023 per ANIP's latest filing, from $0.84 in the prior quarter.
- Over five years, Debt to Equity peaked at $1.07 in Q2 2021 and troughed at $0.8 in Q4 2021.
- A 5-year average of $0.9 and a median of $0.85 in 2022 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2020 and 2022: Debt to Equity grew 8.7% in 2020, then fell 20.16% in 2022.
- Over 5 years, Debt to Equity stood at $0.87 in 2019, then rose by 8.7% to $0.95 in 2020, then declined by 15.57% to $0.8 in 2021, then increased by 5.34% to $0.84 in 2022, then dropped by 0.06% to $0.84 in 2023.
- According to Business Quant data, Debt to Equity over the past three periods registered $0.84, $0.84, and $0.85 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt to Equity (Quarter) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 0.84 |
| Dec 31, 2022 | 0.84 |
| Sep 30, 2022 | 0.85 |
| Jun 30, 2022 | 0.85 |
| Mar 31, 2022 | 0.83 |
| Dec 31, 2021 | 0.80 |
| Sep 30, 2021 | 1.06 |
| Jun 30, 2021 | 1.07 |
| Dec 31, 2020 | 0.95 |
| Dec 31, 2019 | 0.87 |